Prostate Cancer Biomarker May Predict Patient Outcomes, Vanderbilt University Medical Center And University of Alberta Study
Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread. The study, posted online recently in advance of publication in Cancer Research, was led by co-investigators Andries Zijlstra, Ph.D., assistant professor of Pathology, Microbiology and Immunology and Cancer Biology at Vanderbilt, and John Lewis, Ph.D., associate professor of Oncology and Frank and Carla Sojonky Chair in Prostate Cancer Research, University of Alberta.
Hey, check out all the research scientist jobs. Post your resume today!